TORONTO, September 6, 2016 – Bloom Burton & Co. Limited (“Bloom Burton”), Canada’s leading healthcare-specialized investment banking firm, is pleased to announce the appointment of Shawn Aspden as Managing Director of the firm. Mr. Aspden, CFA®, is a highly respected 20-year veteran of the Canadian capital markets, having most recently served as Vice Chairman and Head of North American Institutional Equity Sales at GMP Securities L.P.
In the role of Managing Director, Mr. Aspden will dramatically expand Bloom Burton’s ability to serve Canadian institutional investors as they consider the important pharmaceutical, biotechnology and healthcare sectors. Mr. Aspden will broaden the awareness and distribution of Bloom Burton’s investment banking and advisory capabilities, award-winning equity research, and events such as the firm’s flagship and highly coveted Bloom Burton & Co. Healthcare Investor Conference.
Mr. Aspden will also work to expand the awareness of Bloom Burton Investment Group LP, which currently acts as a consultant to a number of investment funds including the Bloom Burton Canadian Healthcare Fund LP, the Bloom Burton Healthcare Structured Lending Fund I LP, the Bloom Burton Healthcare Structured Lending Fund II LP, the Bloom Burton Healthcare Lending Trust and the Bloom Burton Healthcare Lending Trust II. Mr. Aspden will also contribute to the growth and governance of Bloom Burton’s company incubation affiliate, Bloom Burton Development Corp., which has founded many exciting startups, including Grey Wolf Animal Health Inc., Triumvira Immunologics Inc., Appili Therapeutics Inc. and Qing Bile Therapeutics Inc.
“I am extremely excited to join Canada’s leading healthcare investment dealer,” said Mr. Aspden. “I believe that Bloom Burton, with its scientific and medical professionals, offers unparalleled knowledge of Canadian healthcare for both institutional and corporate accounts. I have always enjoyed working with companies and investors in the healthcare sector, and this new partnership will allow me to work with both established and exciting innovator companies. I look forward to focusing my efforts on healthcare and being a part of Bloom Burton’s continued growth across its platform.”
Brian Bloom, President of Bloom Burton commented, “We are thrilled to have been able to recruit Shawn to join Bloom Burton and partner with us in a leadership role that will touch all aspects of the firm’s growing business. We have dramatically expanded our direct access to institutional investors, and for the first time, many will benefit from our products, our research and our deep understanding and commitment to the Canadian healthcare sector.”
About Bloom Burton & Co.:
Bloom Burton & Co. is a firm dedicated to accelerating returns in the healthcare sector for both investors and companies. Bloom Burton has an experienced team of medical, scientific, pharmaceutical,legal and capital markets professionals who perform a deep level of diligence, which combined with our creative and entrepreneurial approach, assists our clients in achieving the right monetization events. Bloom Burton and its affiliates provide capital raising, M&A advisory, equity research, business strategy and scientific consulting, advisory on direct investing and company creation and incubation services. Bloom Burton & Co. Limited, a member of the Bloom Burton & Co. group of companies, is a member of the Investment Industry Regulatory Organization of Canada (IIROC) and is also a member of the Canadian Investor Protection Fund (CIPF).
For more information, please contact:
Tel: (416) 642-8874
Tel: (416) 640-7580